Eledon Pharmaceuticals's three largest insider shareholders as of September 29, 2026 are Partners L P/Il Bvf (TenPercentOwner, 220.46K shares), David-Alexandre C Gros (Chief Executive Officer, 168.66K shares), Steven Perrin (President, 81.22K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Partners L P/Il Bvf | TenPercentOwner | 220,460 | 0 | 220,460 | 44.4% | 13 May, 2024 |
| 2 | David-Alexandre C Gros | Chief Executive Officer | 168,663 | 0 | 168,663 | 34.0% | 04 Aug, 2026 |
| 3 | Steven Perrin | President | 81,215 | 0 | 81,215 | 16.4% | 04 Aug, 2026 |
| 4 | Keith Katkin | Director | 8,575 | 0 | 8,575 | 1.7% | 16 Jan, 2026 |
| 5 | Jan Hillson | Director | 3,430 | 0 | 3,430 | 0.7% | 16 Jan, 2026 |
| 6 | Allan Kirk | Director | 3,430 | 0 | 3,430 | 0.7% | 16 Jan, 2026 |
| 7 | John S. Mcbride | Chief Operating Officer | 3,430 | 0 | 3,430 | 0.7% | 16 Jan, 2026 |
| 8 | June Lee | Director | 3,430 | 0 | 3,430 | 0.7% | 16 Jan, 2026 |
| 9 | James A. Jr. Robinson | Director | 3,430 | 0 | 3,430 | 0.7% | 16 Jan, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 31 Jul, 2026 | David-Alexandre C Gros | Chief Executive Officer | Acquired A | 354,454 | $0.00 | $0 | 363,454 | Direct |
| 31 Jul, 2026 | Steven Perrin | President | Acquired A | 152,353 | $0.00 | $0 | 153,353 | Direct |
| 31 Jul, 2026 | David-Alexandre C Gros | Chief Executive Officer | Disposed F | 194,791 | $3.38 | $658.39K | 168,663 | Direct |
| 31 Jul, 2026 | Steven Perrin | President | Disposed F | 72,138 | $3.38 | $243.83K | 81,215 | Direct |
| 10 Jan, 2026 | Allan Kirk | Director | Acquired M | 3,430 | $0.00 | $0 | 3,430 | Direct |
| 10 Jan, 2026 | Jan Hillson | Director | Acquired M | 3,430 | $0.00 | $0 | 3,430 | Direct |
| 10 Jan, 2026 | Keith Katkin | Director | Acquired M | 8,575 | $0.00 | $0 | 8,575 | Direct |
| 10 Jan, 2026 | James A. Jr. Robinson | Director | Acquired M | 3,430 | $0.00 | $0 | 3,430 | Direct |
| 10 Jan, 2026 | June Lee | Director | Acquired M | 3,430 | $0.00 | $0 | 3,430 | Direct |
| 10 Jan, 2026 | John S. Mcbride | Director | Acquired M | 3,430 | $0.00 | $0 | 3,430 | Direct |
| 10 Jan, 2026 | Jan Hillson | Director | Disposed M | 3,430 | $0.00 | $0 | 0 | Direct |
| 10 Jan, 2026 | James A. Jr. Robinson | Director | Disposed M | 3,430 | $0.00 | $0 | 0 | Direct |
| 10 Jan, 2026 | Keith Katkin | Director | Disposed M | 8,575 | $0.00 | $0 | 0 | Direct |
| 10 Jan, 2026 | John S. Mcbride | Director | Disposed M | 3,430 | $0.00 | $0 | 0 | Direct |
| 10 Jan, 2026 | Allan Kirk | Director | Disposed M | 3,430 | $0.00 | $0 | 0 | Direct |
| 10 Jan, 2026 | June Lee | Director | Disposed M | 3,430 | $0.00 | $0 | 0 | Direct |
| 10 Jan, 2025 | John S. Mcbride | Director | Acquired A | 30,870 | $0.00 | $0 | 30,870 | Direct |
| 10 Jan, 2025 | June Lee | Director | Acquired A | 30,870 | $0.00 | $0 | 30,870 | Direct |
| 10 Jan, 2025 | Jan Hillson | Director | Acquired A | 30,870 | $0.00 | $0 | 30,870 | Direct |
| 10 Jan, 2025 | Bryan E. Smith | General Counsel, Corporate Sec | Acquired A | 150,500 | $0.00 | $0 | 150,500 | Direct |